WELL Health Technologies Corp.

TSX:WELL Stock Report

Market Cap: CA$1.3b

WELL Health Technologies Management

Management criteria checks 3/4

WELL Health Technologies' CEO is Hamed Shahbazi, appointed in May 2018, has a tenure of 6.5 years. total yearly compensation is CA$6.51M, comprised of 7.7% salary and 92.3% bonuses, including company stock and options. directly owns 5.97% of the company’s shares, worth CA$76.80M. The average tenure of the management team and the board of directors is 5.6 years and 6.6 years respectively.

Key information

Hamed Shahbazi

Chief executive officer

CA$6.5m

Total compensation

CEO salary percentage7.7%
CEO tenure6.5yrs
CEO ownership6.0%
Management average tenure5.6yrs
Board average tenure6.6yrs

Recent management updates

Recent updates

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Nov 11
When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Sep 09
Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Jul 05
Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

Jun 11
WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

May 21
WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Mar 21
WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

Feb 29
Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

Jan 18
The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Oct 30
WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt

Jul 17
We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Apr 18
WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?

Jan 13
Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 40%?

Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?

Nov 11
Should You Think About Buying WELL Health Technologies Corp. (TSE:WELL) Now?

Is WELL Health Technologies Corp. (TSE:WELL) Potentially Undervalued?

Aug 09
Is WELL Health Technologies Corp. (TSE:WELL) Potentially Undervalued?

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price

May 31
WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 43% Above Its Share Price

CEO Compensation Analysis

How has Hamed Shahbazi's remuneration changed compared to WELL Health Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

CA$73m

Jun 30 2024n/an/a

CA$147m

Mar 31 2024n/an/a

CA$30m

Dec 31 2023CA$7mCA$500k

CA$82k

Sep 30 2023n/an/a

-CA$7m

Jun 30 2023n/an/a

-CA$4m

Mar 31 2023n/an/a

-CA$5m

Dec 31 2022CA$2mCA$450k

CA$1m

Sep 30 2022n/an/a

-CA$29m

Jun 30 2022n/an/a

-CA$37m

Mar 31 2022n/an/a

-CA$45m

Dec 31 2021CA$5mn/a

-CA$44m

Sep 30 2021n/an/a

-CA$29m

Jun 30 2021n/an/a

-CA$21m

Mar 31 2021n/an/a

-CA$9m

Dec 31 2020CA$710kn/a

-CA$4m

Sep 30 2020n/an/a

-CA$9m

Jun 30 2020n/an/a

-CA$10m

Mar 31 2020n/an/a

-CA$8m

Dec 31 2019CA$681kn/a

-CA$8m

Dec 31 2018CA$502kn/a

-CA$2m

Compensation vs Market: Hamed's total compensation ($USD4.66M) is above average for companies of similar size in the Canadian market ($USD1.83M).

Compensation vs Earnings: Hamed's compensation has been consistent with company performance over the past year.


CEO

Hamed Shahbazi (49 yo)

6.5yrs

Tenure

CA$6,508,755

Compensation

Mr. Hamed Shahbazi, B. Sc., serves as Chairman & Chief Executive Officer at WELL Ventures. He is Chairman of the Board of Healwell AI Inc. from February 2024. He was Director of Healwell AI Inc. from Octob...


Leadership Team

NamePositionTenureCompensationOwnership
Hamed Shahbazi
Founder6.5yrsCA$6.51m5.97%
CA$ 76.8m
Eva Fong
Chief Financial Officer5.6yrsCA$1.15m0.70%
CA$ 9.0m
Amir Javidan
Chief Operating Officer5.8yrsCA$1.12m0.80%
CA$ 10.3m
James Kreger
CEO of WELL Health USA & CRH Medical2.8yrsCA$1.64mno data
Beemal Shah
COO of CRH Medical Corporation2.2yrsCA$1.58mno data
Pardeep Sangha
Vice President of Corporate Strategy & Investor Relations5.6yrsno datano data
Brian Levinkind
Senior Vice President of Corporate Development5.6yrsCA$302.30kno data
Chris Ericksen
Senior Vice President of Strategic Partnerships & Marketing5.8yrsno datano data
Shane Sabatino
Chief People Officer3.8yrsno datano data
Michael Frankel
Chief Medical Officer6yrsCA$639.73kno data
Michael Goodman
Head of Acquisitions - Eastern Canada4.3yrsno datano data
Iain Paterson
Chief Information Security Officer2.5yrsno datano data

5.6yrs

Average Tenure

55yo

Average Age

Experienced Management: WELL's management team is seasoned and experienced (5.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Hamed Shahbazi
Founder8.7yrsCA$6.51m5.97%
CA$ 76.8m
Thomas Liston
Independent Director6.6yrsCA$257.87k0.26%
CA$ 3.3m
Kenneth Cawkell
Independent Director8.7yrsCA$245.50k0.18%
CA$ 2.4m
John Kim
Independent Director6.8yrsCA$245.50k0.15%
CA$ 2.0m
Patricia Kirkpatrick
Member of Advisory Board5.2yrsno datano data
Tara McCarville
Independent Director4.6yrsCA$245.50k0.039%
CA$ 498.1k
Sybil E. Lau
Independent Director2.3yrsCA$210.24k0.20%
CA$ 2.6m

6.6yrs

Average Tenure

62yo

Average Age

Experienced Board: WELL's board of directors are considered experienced (6.6 years average tenure).